Biocon Limited Announces Earnings for the Half Year Ended September 30, 2011 - Business Wire India (press release) PDF Print
Business Wire India (press release)
Nephrology – The second quarter of FY12 saw the Nephrology business unit deliver a strong double-digit growth of 18% driven by a strong 25% growth in the renal transplant portfolio comprising of TacrografTM, RenodaptTM, and Cyclophil METM.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.